首页|University of Alabama at Birmingham Reports Findings in Oropharyngeal Cancer (In terim Phase II Results Using Panitumumab- IRDye800CW During Transoral Robotic Sur gery in Patients with Oropharyngeal Cancer)
University of Alabama at Birmingham Reports Findings in Oropharyngeal Cancer (In terim Phase II Results Using Panitumumab- IRDye800CW During Transoral Robotic Sur gery in Patients with Oropharyngeal Cancer)
扫码查看
点击上方二维码区域,可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News – New research on Oncology - Oropharynge al Cancer is the subject of a report. Accordingto news reporting from Birmingha m, Alabama, by NewsRx journalists, research stated, “The incidenceof oropharyng eal squamous cell carcinoma (OPSCC) has continually increased during the past se veraldecades. Using transoral robotic surgery (TORS) significantly improves fun ctional outcomes relative toopen surgery for OPSCC.”
BirminghamAlabamaUnited StatesNort h and Central AmericaCancerClinical ResearchClinical Trials and StudiesE merging TechnologiesHealth and MedicineMachine LearningOncologyOropharyn geal CancerRobotRoboticsRobotsSurgery